- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04096521
Serum Folic Acid Status, Genotyping MTHFR 677C-->T, Plasma Homocysteine, DNA Methylation of IGF2 Gene and Microbiota of the Children: Mother-Children Cohort Study
December 29, 2019 updated by: Lestari Octavia, Indonesia University
Serum Folic Acid Status, Genotyping MTHFR 677C-->T of the Mother and Serum Folic Acid Status, DNA Methylation of IGF2 Gene of the Children: East Jakarta Cohort Study
This study is part of the East Jakarta Cohort Study to assess the current micronutrient status of the mothers and their children.
The study also includes the assessment of genotyping of MTHFR 677C-->T of the mother and DNA methylation of IGF2 gene of the children.
Study Overview
Status
Completed
Conditions
Detailed Description
The initial study recruited 315 mothers in the public health centre and one district hospital in East Jakarta.
The follow-up study is able to re-visit the 127 of them.
This also includes 127 peers of the subject that lives in the same neighbourhood.
The design of the study is case-cohort design, part study of the existing cohort.
The assessment of the follow-up study includes the mother and the children born in the initial study.
Anthropometric measurement, socioeconomic data from a structured questionnaire, biomarker assessment, blood pressure were obtained from the subjects.
Study Type
Observational
Enrollment (Actual)
254
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
DKI Jakarta
-
Jakarta, DKI Jakarta, Indonesia, 10430
- Universitas Indonesia
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
3 years to 40 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
In 2014, the pregnant mothers in 10 public health centre and one sub-district hospital in East Jakarta were recruited in the study.
They were in the third trimester gestation period, receive iron-folic acid supplementation and ANC.
In 2018, the repeated collection was conducted to collect follow-up data.
We also include peer of the subjects that lived in the same neighbourhood since the first cohort study and have children in the same age with cohort participant
Description
Inclusion Criteria:
- participant in the previous study
- apparently healthy
- data complete
- voluntarily to participate
Exclusion Criteria:
- not complete data
- migrate
- refuse to participate in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
|---|
|
East Jakarta Cohort Study
One group included in the study was originated from mothers who participated in the first data collection pregnancy.
The follow-up study included mothers and their children born as the subject in the follow-up in the study.
This study also includes peer of the subjects that lived in the same neighbourhood since the first cohort study and have children in the same age with cohort participant
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Serum folic acid status
Time Frame: December 2018 - March 2019
|
The measurement of serum folic acid status is using LC-MS/MS
|
December 2018 - March 2019
|
|
Genotyping MTHFR 677C-->T
Time Frame: December 2018 - March 2019
|
The assessment of MTHFR 677C-->T using Real Time PCR
|
December 2018 - March 2019
|
|
DNA methylation of IGF2 gene
Time Frame: December 2018 - March 2019
|
DNA methylation of IGF2 gene using pyrosequencing method
|
December 2018 - March 2019
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Serum Homocysteine
Time Frame: December 2018-March 2019
|
The measurement of serum homocysteine using Electrochemiluminescen
|
December 2018-March 2019
|
|
Serum Adiponectin
Time Frame: December 2018-March 2019
|
The measurement of serum adiponection using electrochemiluminescence
|
December 2018-March 2019
|
|
Blood pressure
Time Frame: December 2018-March 2019
|
The blood pressure measurement using semi automatic device (Omron HBP1300)
|
December 2018-March 2019
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Nutritional status assessment
Time Frame: September 2018-December 2018
|
Using antrhopometric measurement, using SECA for weight measurement, Shorrboard for height and standardized plastic tape for mid upper arm circumference.
|
September 2018-December 2018
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Rina RA Agustina, Doctoral, Indonesia University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 2, 2018
Primary Completion (Actual)
November 20, 2018
Study Completion (Actual)
March 16, 2019
Study Registration Dates
First Submitted
September 18, 2019
First Submitted That Met QC Criteria
September 19, 2019
First Posted (Actual)
September 20, 2019
Study Record Updates
Last Update Posted (Actual)
January 2, 2020
Last Update Submitted That Met QC Criteria
December 29, 2019
Last Verified
December 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0420/UN2.F1/ETIK/2018
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
I will not share the IPD of the subject participated due to consent issue
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Folic Acid Deficiency
-
Hadassah Medical OrganizationUnknown
-
Harvard UniversityCompleted
-
Oklahoma State University Center for Health SciencesActive, not recruiting
-
Mansoura UniversitySwedish University of Agricultural Sciences; The Swedish Research Council for...Completed
-
National Institute of Health and NutritionCompletedFolate Deficiency
-
University Hospital, Strasbourg, FranceCompletedFolic Acid Deficiency | Elderly Patients | Social IsolationFrance
-
Meir Medical CenterCompletedFolic Acid Deficiency | Vitamin B12 DeficiencyIsrael
-
University of TorontoThe Hospital for Sick Children; Heinz EndowmentsCompletedIron Deficiency | Folic Acid DeficiencyCanada
-
Walden UniversityCompletedPregnancy Related | Autism Spectrum Disorder | Autistic Disorder | Folate Deficiency | Folic Acid Deficiency | Diet, Healthy | Autism | Diet; Deficiency | Folic Acid OverdoseUnited States
-
Medical University of GrazCompletedHealthy | Oxidative Stress | Vitamin B 12 Deficiency | Polyphenols | Thiamine and Niacin Deficiency States | Pyridoxine Deficiency | Folic Acid Deficiency Anemia, Dietary | Peroxidase; Defect | Homocystine; Metabolic DisorderAustria